Author
Listed:
- S. Lidiya
(School of Pharmacy, Anurag University, Venkatapur, Ghatkesar, Medchal-Malkajgiri, Hyderabad, Telangana – 500 088, India)
- U. Meenakshi
(School of Pharmacy, Anurag University, Venkatapur, Ghatkesar, Medchal-Malkajgiri, Hyderabad, Telangana – 500 088, India)
- K. Mounika
(Department of Pharmaceutics, School of Pharmacy, Anurag University, Venkatapur, Ghatkesar, Medchal-Malkajgiri, Hyderabad, Telangana – 500 088, India)
- J. Rajendra Kumar
(Department of Pharmaceutics, School of Pharmacy, Anurag University, Venkatapur, Ghatkesar, Medchal-Malkajgiri, Hyderabad, Telangana – 500 088, India)
Abstract
To develop empaglifazon nanosuspension by Solvent evaporation technique using ethanol as organic phase then aqueous phase was prepared by dissolving acetate cellulose in water then add poloxamer-188 and sodium lauryl sulphate. Physicochemical properties like melting point, solubility, particle size and shape, in-vitro diffusion studies etc. were performed for the prepared nanosuspension formulations. Based on drug excipient compatibility studies such as FTIR images shown that there is no interaction between drug and excipients. XRD studies revealed the crystalline structure of the formulation. A surface characteristic was determined by SEM. In-vitro diffusion studies were carried out by Franz diffusion cell, found the ranges around 95% for both pure and optimized formulations. Research indicates that the Empagliflozin nanosuspension is optimal for prolonged and extended release. This nanosuspension has been found to effectively reduce diabetes mellitus when taken orally.
Suggested Citation
S. Lidiya & U. Meenakshi & K. Mounika & J. Rajendra Kumar, 2025.
"Design, Formulation Development and Characterization of Empagliflozin Nanosuspension,"
International Journal of Research and Scientific Innovation, International Journal of Research and Scientific Innovation (IJRSI), vol. 12(6), pages 1392-1401, June.
Handle:
RePEc:bjc:journl:v:12:y:2025:i:6:p:1392-1401
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjc:journl:v:12:y:2025:i:6:p:1392-1401. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrsi/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.